Brownstone Institute
Listen to the Kids
From the Brownstone Institute
BY
People often ask me why I still care about school closures and other covid restrictions that harmed a generation of children. “Schools are open now,” they say. “It’s enough already.”
No. It’s not. The impact to this generation of children continues. And so do many of the restrictions impacting young people.
It was just this week that New York City public schools lifted the ban on unvaccinated parents entering public school buildings.
This meant a parent who was unvaccinated could not attend a parent-teacher conference in person. Or watch their child play basketball. They could, however, attend a Knicks’ game at Madison Square Garden with 20,000 other basketball fans. This rule seemed designed specifically to punish children.
Colleges are some of the last places requiring vaccination — even boosters, in some instances, like at Fordham University. These young adults are least at risk from covid, most at risk from vaccine-induced myocarditis and are some of the last Americans required to be boosted. It makes no sense.
Rather than do my own rant about why I still care about the lasting harm done to children, I’d like to let the kids and parents speak for themselves.
The teens and parents cited below are all featured in a documentary film I’m making. I want their stories told. This all needs to be documented because the narrative is already shifting:
“Yeah schools shouldn’t have been closed so long but how could we have known! It’s over now. Time to move on.”
“Let’s declare an amnesty. We need to forgive the hard calls people needed to make without enough information. Good people did the best they could!”
“The open-schoolers may have been right but for the wrong reasons so they’re still terrible people. And besides it’s not a competition! No gloating! Let’s focus on the future!”
But it’s not over. The kids are not alright. And there is insufficient focus on how to reintegrate them and help them recover. This article, from the New York Times on January 27, lays bare the harms done, the possible lifetime effects, and the lack of attention and care being paid to helping kids recover:


I will continue to advocate for them, to tell their stories, to try to get them the help they still need and deserve. And to ensure this never happens again.
It’s time we listened to the children and parents impacted.
Garrett “Bam” Morgan, Jr., high school student. Astoria Queens, NY:
“I was so upset. Why is it that someone who pays for school and has more money to throw around . . .why do they get to play football? And I don’t. What is the difference? Because we’re playing the same sport. It’s not like they’re playing something totally drastically different. It’s the same sport. We’re doing the same things, and they get to practice, they get to play. And I don’t, and for me it was just like, why? Why me? Why my teammates? Why is it that we don’t get to have fun? Why is it that we don’t get to play the sport that we love too? How am I going to get into a college if I don’t have a junior year of football?
“I was gaining weight. And I was getting in a place where I had to start thinking of alternatives to football, thinking of life without football. Then I would try and go out and play with my friends, towards 2021 when it started to become, okay, you can somewhat go out, just stay socially distanced. But by that time, the damage was done, right?”
Scarlett Nolan, high school student. Oakland, CA:
“I didn’t make any new friends. No one did. I mean, how could you, you’re just talking to literal black boxes on a computer.”
“I don’t wanna blame it all on school closures, but it’s been a really, really big thing for me. That’s changed my life so much. That’s not how it’s supposed to go in school. You’re supposed to have school. It’s supposed to be your life. School is supposed to be your life from kindergarten to senior year. And then you go to college if you want, but that’s supposed to be your life. That’s your education. You have your friends there, you find yourself there. You find how you wanna be when you grow up there. And without that, I lost who I was completely. Everything who I was. I wasn’t that person that worked to get straight A’s anymore. I didn’t care. I was just sad.”
Ellie O’Malley, Scarlett’s mom. Oakland, CA:
“She had finished her eighth grade. She had missed everything. She’d missed her graduation. She’d missed this trip to Washington. And then she started her new school [high school] on-line. [She was] very disengaged, never saw people’s faces, no one had the camera on. I mean it was school in like the thinnest most loose [sense] of the word. For the most part it was pretty dire and terrible. By January 2021, she really just no longer had the motivation to do it. She wasn’t getting out of bed. She was really depressed at that point.”
“A lot of it was just mental health, suicidal tendencies, self-harm. The first time Scarlett went to hospital, she kind of had a bit of a nervous breakdown. I’d never experienced that. She was screaming and clawing at herself. And we were like, what do we do? What do we do?”
Miki Sedivy, a mom who lost her teenaged daughter Hannah to an accidental drug overdose in 2021. Lakewood, CO:
“You’re taking children out of their natural environment of playing with each other, interacting socially and learning coping skills by interacting with other children. And when you take all of that away and all of a sudden these kids are in isolation, they mentally don’t know how to handle it. We can go [through] short times of isolation, but we’re talking a year and a half. [That’s] of a lot of isolation.”
Jennifer Dale. Her 11-year-old daughter has Down syndrome. Lake Oswego, OR.
“The school closures were devastating for her. I don’t think I realized it at first. At first I thought it was safer. Lizzie, a child with Down syndrome, was probably more susceptible to a respiratory virus. She’s had more respiratory issues than her siblings. So at first I thought it was the right thing to do As time went on, I don’t think people realized how isolated she was. She doesn’t have a means of reaching out and saying Hey, how you doing? I miss you. I wanna see you.”
“What Lizzie really needs is to look at her peers and how are they zipping up their jacket, or how are they coming in in the morning and making a food selection for lunch. That peer interaction and that peer role modeling is some of the best learning that my daughter can experience. But that role modeling is gone. When you’re online she doesn’t get to see what the other kids are doing. She wasn’t out seeing people. Nobody knew that she was struggling. It was all in our house. It was impossible for a young person with cognitive delays to understand why, why was the world suddenly closed? Why suddenly could I not see my friends? Why am I only seeing them on a screen and how do I interact?”
Am’Brianna Daniels, high school student. San Francisco, CA.
“As time moved on, like later in the year, I started to realize I really wanted to be back in school. I was 24/7 [on Zoom] and I think that’s what took a toll on me. . . I actually stayed doing Zoom in my living room that way I wasn’t tempted to fall asleep or anything. This did not help. I still did fall asleep sometimes.”
“I had like very little motivation to actually get up, get on Zoom and attend class. And then I think coming up on the year anniversary of the initial lockdown and then the lack of social interaction is kind of what took a toll on my mental health since I am such a social person. And so it really got to a point where I was just not going to class.”
“And it got really bad to the point where I was either over-eating or just not eating very much, and I was kind of dehydrated during my depressive moods. And eventually I did get in contact with the therapist. It helped a little bit, but not to the extent that I would have hoped.
Nelson Ropati, high school student. San Francisco, CA.
“I just didn’t like staring at a screen for an hour for class. I just couldn’t do it. I would fall asleep or just lose focus easily.”
“It wasn’t really mandatory to go to class. So I ain’t gonna lie. I didn’t really go to class the rest of my junior year when covid hit and they kind of just passed everyone.”

Lorna Ropati, Nelson’s mom. San Francisco, CA.
“I felt bad for him because then that’s when he started doing nothing else, but just like eating. I said you’re not hungry. It’s just a habit. Don’t go to the fridge. He just mainly stayed home and did whatever he could through his on-line courses and just stayed home. I think he didn’t go out of the house at one point for six months. He didn’t go nowhere. He never even stepped out of the house. So that was not good. I said, you need to get out, you need to stop being in this little shell and bubble that you’re in. It’s okay. You can go out.”
Jim Kuczo, lost his son Kevin to suicide in 2021. Fairfield, CT.
“Well we were very concerned because of the grades — that was the tip off. But again, it was hard because you can’t go out with your friends. We were concerned. We asked the guidance counselor and the therapist, is he suicidal? They said no.”
“You cannot treat kids like prisoners and expect them to be okay. I think that we, our leaders, put most of the burden on children.”
“I went through lots of guilt — what did I do to cause my son to kill himself.”
Kristen Kuczo, Kevin’s mom. Fairfield, CT.
“He [Kevin] wound up not playing football and then we kind of just started noticing he just was doing less and less. His grades were starting to drop. Really the biggest red flag for me was the grades dropping.”
“The day after he took his life, I was supposed to be having a meeting with the guidance counselors and we were looking into getting him a 504, which would allow him extra time to do things and possibly on exams. We were pursuing that as a possibility to try to help support him in the school setting. Because he had spoken to us about having trouble focusing and feeling like he just couldn’t do it.”
“All these doctors, they weren’t taking anybody. They weren’t taking patients because they were full. They didn’t have any space to take on new clients. It was shocking. So I didn’t have an appointment with a psychiatrist until about a week and a half after Kevin passed.”

I’ll leave you with a few words from Garrett Morgan, Jr. He’s struggling to get his life back on track. To get his grades back up. To lose the 80 pounds he gained. To get back in shape. To play football again. To get that college scholarship.
He’s a fighter. And I have confidence he’ll succeed. But he won’t forget what he and his peers lost, what was taken from them, and how much tougher his road ahead is because of it.


“This is something that my generation will not forget. This is also something that my generation will not forgive. The memories that we have lost, the experiences that we have lost, the skills that we have lost because of covid. And now we have to regain that and go out into the world. It is going to be something that will define us.”
Reposted from the author’s Substack
Brownstone Institute
Bizarre Decisions about Nicotine Pouches Lead to the Wrong Products on Shelves
From the Brownstone Institute
A walk through a dozen convenience stores in Montgomery County, Pennsylvania, says a lot about how US nicotine policy actually works. Only about one in eight nicotine-pouch products for sale is legal. The rest are unauthorized—but they’re not all the same. Some are brightly branded, with uncertain ingredients, not approved by any Western regulator, and clearly aimed at impulse buyers. Others—like Sweden’s NOAT—are the opposite: muted, well-made, adult-oriented, and already approved for sale in Europe.
Yet in the United States, NOAT has been told to stop selling. In September 2025, the Food and Drug Administration (FDA) issued the company a warning letter for offering nicotine pouches without marketing authorization. That might make sense if the products were dangerous, but they appear to be among the safest on the market: mild flavors, low nicotine levels, and recyclable paper packaging. In Europe, regulators consider them acceptable. In America, they’re banned. The decision looks, at best, strange—and possibly arbitrary.
What the Market Shows
My October 2025 audit was straightforward. I visited twelve stores and recorded every distinct pouch product visible for sale at the counter. If the item matched one of the twenty ZYN products that the FDA authorized in January, it was counted as legal. Everything else was counted as illegal.
Two of the stores told me they had recently received FDA letters and had already removed most illegal stock. The other ten stores were still dominated by unauthorized products—more than 93 percent of what was on display. Across all twelve locations, about 12 percent of products were legal ZYN, and about 88 percent were not.
The illegal share wasn’t uniform. Many of the unauthorized products were clearly high-nicotine imports with flashy names like Loop, Velo, and Zimo. These products may be fine, but some are probably high in contaminants, and a few often with very high nicotine levels. Others were subdued, plainly meant for adult users. NOAT was a good example of that second group: simple packaging, oat-based filler, restrained flavoring, and branding that makes no effort to look “cool.” It’s the kind of product any regulator serious about harm reduction would welcome.
Enforcement Works
To the FDA’s credit, enforcement does make a difference. The two stores that received official letters quickly pulled their illegal stock. That mirrors the agency’s broader efforts this year: new import alerts to detain unauthorized tobacco products at the border (see also Import Alert 98-06), and hundreds of warning letters to retailers, importers, and distributors.
But effective enforcement can’t solve a supply problem. The list of legal nicotine-pouch products is still extremely short—only a narrow range of ZYN items. Adults who want more variety, or stores that want to meet that demand, inevitably turn to gray-market suppliers. The more limited the legal catalog, the more the illegal market thrives.
Why the NOAT Decision Appears Bizarre
The FDA’s own actions make the situation hard to explain. In January 2025, it authorized twenty ZYN products after finding that they contained far fewer harmful chemicals than cigarettes and could help adult smokers switch. That was progress. But nine months later, the FDA has approved nothing else—while sending a warning letter to NOAT, arguably the least youth-oriented pouch line in the world.
The outcome is bad for legal sellers and public health. ZYN is legal; a handful of clearly risky, high-nicotine imports continue to circulate; and a mild, adult-market brand that meets European safety and labeling rules is banned. Officially, NOAT’s problem is procedural—it lacks a marketing order. But in practical terms, the FDA is punishing the very design choices it claims to value: simplicity, low appeal to minors, and clean ingredients.
This approach also ignores the differences in actual risk. Studies consistently show that nicotine pouches have far fewer toxins than cigarettes and far less variability than many vapes. The biggest pouch concerns are uneven nicotine levels and occasional traces of tobacco-specific nitrosamines, depending on manufacturing quality. The serious contamination issues—heavy metals and inconsistent dosage—belong mostly to disposable vapes, particularly the flood of unregulated imports from China. Treating all “unauthorized” products as equally bad blurs those distinctions and undermines proportional enforcement.
A Better Balance: Enforce Upstream, Widen the Legal Path
My small Montgomery County survey suggests a simple formula for improvement.
First, keep enforcement targeted and focused on suppliers, not just clerks. Warning letters clearly change behavior at the store level, but the biggest impact will come from auditing distributors and importers, and stopping bad shipments before they reach retail shelves.
Second, make compliance easy. A single-page list of authorized nicotine-pouch products—currently the twenty approved ZYN items—should be posted in every store and attached to distributor invoices. Point-of-sale systems can block barcodes for anything not on the list, and retailers could affirm, once a year, that they stock only approved items.
Third, widen the legal lane. The FDA launched a pilot program in September 2025 to speed review of new pouch applications. That program should spell out exactly what evidence is needed—chemical data, toxicology, nicotine release rates, and behavioral studies—and make timely decisions. If products like NOAT meet those standards, they should be authorized quickly. Legal competition among adult-oriented brands will crowd out the sketchy imports far faster than enforcement alone.
The Bottom Line
Enforcement matters, and the data show it works—where it happens. But the legal market is too narrow to protect consumers or encourage innovation. The current regime leaves a few ZYN products as lonely legal islands in a sea of gray-market pouches that range from sensible to reckless.
The FDA’s treatment of NOAT stands out as a case study in inconsistency: a quiet, adult-focused brand approved in Europe yet effectively banned in the US, while flashier and riskier options continue to slip through. That’s not a public-health victory; it’s a missed opportunity.
If the goal is to help adult smokers move to lower-risk products while keeping youth use low, the path forward is clear: enforce smartly, make compliance easy, and give good products a fair shot. Right now, we’re doing the first part well—but failing at the second and third. It’s time to fix that.
Addictions
The War on Commonsense Nicotine Regulation
From the Brownstone Institute
Cigarettes kill nearly half a million Americans each year. Everyone knows it, including the Food and Drug Administration. Yet while the most lethal nicotine product remains on sale in every gas station, the FDA continues to block or delay far safer alternatives.
Nicotine pouches—small, smokeless packets tucked under the lip—deliver nicotine without burning tobacco. They eliminate the tar, carbon monoxide, and carcinogens that make cigarettes so deadly. The logic of harm reduction couldn’t be clearer: if smokers can get nicotine without smoke, millions of lives could be saved.
Sweden has already proven the point. Through widespread use of snus and nicotine pouches, the country has cut daily smoking to about 5 percent, the lowest rate in Europe. Lung-cancer deaths are less than half the continental average. This “Swedish Experience” shows that when adults are given safer options, they switch voluntarily—no prohibition required.
In the United States, however, the FDA’s tobacco division has turned this logic on its head. Since Congress gave it sweeping authority in 2009, the agency has demanded that every new product undergo a Premarket Tobacco Product Application, or PMTA, proving it is “appropriate for the protection of public health.” That sounds reasonable until you see how the process works.
Manufacturers must spend millions on speculative modeling about how their products might affect every segment of society—smokers, nonsmokers, youth, and future generations—before they can even reach the market. Unsurprisingly, almost all PMTAs have been denied or shelved. Reduced-risk products sit in limbo while Marlboros and Newports remain untouched.
Only this January did the agency relent slightly, authorizing 20 ZYN nicotine-pouch products made by Swedish Match, now owned by Philip Morris. The FDA admitted the obvious: “The data show that these specific products are appropriate for the protection of public health.” The toxic-chemical levels were far lower than in cigarettes, and adult smokers were more likely to switch than teens were to start.
The decision should have been a turning point. Instead, it exposed the double standard. Other pouch makers—especially smaller firms from Sweden and the US, such as NOAT—remain locked out of the legal market even when their products meet the same technical standards.
The FDA’s inaction has created a black market dominated by unregulated imports, many from China. According to my own research, roughly 85 percent of pouches now sold in convenience stores are technically illegal.
The agency claims that this heavy-handed approach protects kids. But youth pouch use in the US remains very low—about 1.5 percent of high-school students according to the latest National Youth Tobacco Survey—while nearly 30 million American adults still smoke. Denying safer products to millions of addicted adults because a tiny fraction of teens might experiment is the opposite of public-health logic.
There’s a better path. The FDA should base its decisions on science, not fear. If a product dramatically reduces exposure to harmful chemicals, meets strict packaging and marketing standards, and enforces Tobacco 21 age verification, it should be allowed on the market. Population-level effects can be monitored afterward through real-world data on switching and youth use. That’s how drug and vaccine regulation already works.
Sweden’s evidence shows the results of a pragmatic approach: a near-smoke-free society achieved through consumer choice, not coercion. The FDA’s own approval of ZYN proves that such products can meet its legal standard for protecting public health. The next step is consistency—apply the same rules to everyone.
Combustion, not nicotine, is the killer. Until the FDA acts on that simple truth, it will keep protecting the cigarette industry it was supposed to regulate.
-
Alberta14 hours agoPremier Smith explains how private clinics will be introduced in Alberta
-
Health2 days agoTens of thousands are dying on waiting lists following decades of media reluctance to debate healthcare
-
Opinion2 days agoLandmark 2025 Study Says Near-Death Experiences Can’t Be Explained Away
-
Alberta13 hours agoAlberta introducing dual practice health care model to increase options and shorten wait times while promising protection for publicly funded services
-
Aristotle Foundation10 hours agoWe’re all “settlers”
-
Business13 hours agoUS Supreme Court may end ‘emergency’ tariffs, but that won’t stop the President
-
Carbon Tax2 days agoCarney fails to undo Trudeau’s devastating energy policies
-
Business2 days agoBudget 2025: Ottawa Fakes a Pivot and Still Spends Like Trudeau




